Legal & General Group PLC Haemonetics Corp Transaction History

Legal & General Group PLC

  • $470 Billion
  • Q3 2024

A detailed history of Legal & General Group PLC transactions in Haemonetics Corp stock. As of the latest transaction made, Legal & General Group PLC holds 86,909 shares of HAE stock, worth $7.75 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
86,909
Previous 86,909 -0.0%
Holding current value
$7.75 Million
Previous $6.98 Million -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$72.45 - $91.58 $53,975 - $68,227
745 Added 0.86%
86,909 $6.98 Million
Q2 2024

Aug 14, 2024
BUY
$81.24 - $97.37 $408,555 - $489,673
5,029 Added 6.2%
86,164 $7.13 Million
Q1 2024

Jul 01, 2024
BUY
$71.24 - $85.35 $201,181 - $241,028
2,824 Added 3.61%
81,135 $6.92 Million
Q1 2024

May 14, 2024
SELL
$71.24 - $85.35 $119,398 - $143,046
-1,676 Reduced 2.1%
78,311 $6.68 Million
Q4 2023

Feb 15, 2024
SELL
$80.59 - $92.61 $82,201 - $94,462
-1,020 Reduced 1.26%
79,987 $6.84 Million
Q3 2023

Nov 14, 2023
BUY
$82.56 - $93.49 $107,410 - $121,630
1,301 Added 1.63%
81,007 $7.26 Million
Q2 2023

Aug 14, 2023
BUY
$80.84 - $89.45 $96,927 - $107,250
1,199 Added 1.53%
79,706 $6.79 Million
Q1 2023

May 15, 2023
BUY
$72.75 - $90.6 $64,529 - $80,362
887 Added 1.14%
78,507 $6.5 Million
Q4 2022

Feb 14, 2023
BUY
$73.85 - $86.14 $29,983 - $34,972
406 Added 0.53%
77,620 $6.1 Million
Q3 2022

Nov 14, 2022
SELL
$63.3 - $78.66 $74,061 - $92,032
-1,170 Reduced 1.49%
77,214 $5.72 Million
Q2 2022

Aug 22, 2022
BUY
$49.27 - $66.08 $218,709 - $293,329
4,439 Added 6.0%
78,384 $5.11 Million
Q1 2022

May 16, 2022
BUY
$43.77 - $63.22 $10,154 - $14,667
232 Added 0.31%
73,945 $4.68 Million
Q4 2021

Feb 14, 2022
BUY
$49.55 - $74.59 $7,928 - $11,934
160 Added 0.22%
73,713 $3.91 Million
Q3 2021

Nov 15, 2021
BUY
$57.6 - $70.59 $535,104 - $655,781
9,290 Added 14.46%
73,553 $5.19 Million
Q2 2021

Aug 12, 2021
SELL
$51.81 - $118.56 $2.64 Million - $6.04 Million
-50,986 Reduced 44.24%
64,263 $4.28 Million
Q1 2021

May 17, 2021
BUY
$111.01 - $139.48 $66,939 - $84,106
603 Added 0.53%
115,249 $12.8 Million
Q4 2020

Feb 12, 2021
SELL
$88.75 - $119.95 $1.56 Million - $2.1 Million
-17,525 Reduced 13.26%
114,646 $13.6 Million
Q3 2020

Nov 13, 2020
BUY
$75.65 - $93.58 $753,625 - $932,243
9,962 Added 8.15%
132,171 $11.5 Million
Q2 2020

Aug 14, 2020
BUY
$84.96 - $118.91 $2.51 Million - $3.51 Million
29,521 Added 31.85%
122,209 $10.9 Million
Q1 2020

May 14, 2020
SELL
$74.34 - $121.82 $104,522 - $171,278
-1,406 Reduced 1.49%
92,688 $9.24 Million
Q4 2019

Feb 13, 2020
BUY
$114.37 - $129.46 $901,464 - $1.02 Million
7,882 Added 9.14%
94,094 $10.8 Million
Q3 2019

Nov 13, 2019
BUY
$117.16 - $138.52 $81,543 - $96,409
696 Added 0.81%
86,212 $10.9 Million
Q2 2019

Aug 14, 2019
BUY
$81.74 - $120.34 $2.14 Million - $3.15 Million
26,181 Added 44.12%
85,516 $10.3 Million
Q1 2019

May 15, 2019
BUY
$83.25 - $102.12 $73,176 - $89,763
879 Added 1.5%
59,335 $5.19 Million
Q4 2018

Feb 15, 2019
BUY
$90.66 - $116.63 $233,812 - $300,788
2,579 Added 4.62%
58,456 $5.85 Million
Q3 2018

Nov 20, 2018
SELL
$89.96 - $114.58 $64,951 - $82,726
-722 Reduced 1.28%
55,877 $6.4 Million
Q2 2018

Aug 10, 2018
SELL
$71.53 - $95.75 $3.89 Million - $5.21 Million
-54,381 Reduced 49.0%
56,599 $5.08 Million
Q1 2018

May 17, 2018
BUY
$60.72 - $74.41 $307,425 - $376,737
5,063 Added 4.78%
110,980 $8.11 Million
Q4 2017

Feb 13, 2018
BUY
$44.96 - $58.99 $4.76 Million - $6.25 Million
105,917
105,917 $6.15 Million

Others Institutions Holding HAE

# of Institutions
334
Shares Held
54M
Call Options Held
689K
Put Options Held
345K
View Full List

About HAEMONETICS CORP

HAE Quotes by TradingView
  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $4.58B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email